Stock Analysis

CSL Full Year 2024 Earnings: EPS Misses Expectations

ASX:CSL
Source: Shutterstock

CSL (ASX:CSL) Full Year 2024 Results

Key Financial Results

  • Revenue: US$14.8b (up 11% from FY 2023).
  • Net income: US$2.64b (up 20% from FY 2023).
  • Profit margin: 18% (up from 17% in FY 2023). The increase in margin was driven by higher revenue.
  • EPS: US$5.47 (up from US$4.55 in FY 2023).
earnings-and-revenue-growth
ASX:CSL Earnings and Revenue Growth August 13th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

CSL EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.2%.

Looking ahead, revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Biotechs industry in Australia.

Performance of the Australian Biotechs industry.

The company's shares are down 2.5% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with CSL.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.